Abstract
A new potentiometric immunoassay protocol for the determination of carcinoembryonic antigen (CEA) in human serum was designed by using a novel transparent immunoaffinity reactor. To construct such an affinity reactor, Fe3O4 nanorods with average diameter of 40 nm and length of 1.0 μm were initially synthesized through hydrolysis of FeCl3 and FeSO4 in the urea solution, and then the synthesized nanorods were used as the immobilized affinity support for the conjugation of anti-CEA antibodies (bionanorods). With an external magnet, the magnetic bionanorods were attached to the surface of a self-made carbon paste electrode. The performance and factors influencing the immunosensors were evaluated. Under optimal conditions, the binding of CEA in the samples onto the immobilized anti-CEA changed the potential response, a dynamic range from 1.5 to 80 ng·mL−1, and a detection limit of 0.9 ng·mL−1 CEA (at 3σ). The immunosensors show good precision, high sensitivity, acceptable stability and reproducibility. The CEA concentrations of the clinical serum specimens assayed by the immunosensor show consistent results in comparison with those obtained by commercially available enzyme-linked immunosorbent assay.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
